Growth hormone response to thyrotropin-relesing hormone in cancer patients.
Open Access
- 1 January 1980
- journal article
- research article
- Published by Japan Endocrine Society in Endocrinologia Japonica
- Vol. 27 (4) , 451-455
- https://doi.org/10.1507/endocrj1954.27.451
Abstract
Plasma GH responses to TRH were investigated in 50 cancer patients. Out of 50 cancer patients, 33 were found to be responders. At 15, 30 and 60 min after TRH injection, the mean values GH for cancer patients was significantly higher than the corresponding value for normal controls and the base-line level following saline injection in cancer patients (p<0.001). Our results suggests that a possible alteration of hypothalamic-pituitary function regulating GH secretion may occur in patients with cancer.This publication has 3 references indexed in Scilit:
- Effect of Thyrotropin-Releasing Hormone and Bromoergocriptine on Growth Hormone and Prolactin Secretion in Perfused Pituitary Adenoma Tissues of AcromegalyJournal of Clinical Endocrinology & Metabolism, 1978
- Growth Hormone and Prolactin Responses to Thyrotropin- Releasing Hormone in Patients with Severe Liver DiseaseJournal of Clinical Endocrinology & Metabolism, 1977
- Increase in Plasma Growth Hormone Levels Following Thyrotropin-Releasing Hormone Injection in Children with Primary HypothyroidismJournal of Clinical Endocrinology & Metabolism, 1977